Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis - Takeaways - MDSpire

Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis

  • By

  • Peng Zhang

  • Fangjie Zhu

  • Yunting Xiao

  • Zhengdong Shen

  • Chunxiao Fan

  • Peifeng Ke

  • Yao Xu

  • Chenguang Zhan

  • Xin Li

  • Xiaodong Wu

  • Liyan Mei

  • Kaixin Gao

  • Haifang Du

  • Xiumin Chen

  • Yang Jiao

  • Runyue Huang

  • Maojie Wang

  • May 26, 2026

  • 0 min

Share

  • 1

    Gouty arthritis is characterized by acute flares due to monosodium urate crystal deposition, leading to inflammation and potential chronic joint damage.

  • 2

    The study utilized Mendelian randomization, CyTOF immune profiling, and plasma proteomics to explore immune features in acute gouty arthritis.

  • 3

    Mass cytometry revealed expansion and functional remodeling of CD4+ naïve T cells during acute gout flares, indicating adaptive immune involvement.

  • 4

    Elevated levels of MMP1 and S100A12 were identified during acute flares, correlating with systemic inflammatory markers like high-sensitivity C-reactive protein.

  • 5

    MMP1 showed potential for predicting 12-week recurrence risk in acute gouty arthritis, particularly in patients experiencing acute flares.

Original Source(s)

Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis

  • by Peng Zhang, Fangjie Zhu, Yunting Xiao, Zhengdong Shen, Chunxiao Fan, Peifeng Ke, Yao Xu, Chenguang Zhan, Xin Li, Xiaodong Wu, Liyan Mei, Kaixin Gao, Haifang Du, Xiumin Chen, Yang Jiao, Runyue Huang, Maojie Wang

  • May 26, 2026

Related Content

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.

Childhood-onset systemic lupus erythematosus presenting with growth retardation and delayed puberty: a case report